share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/01 16:11

Moomoo AI 已提取核心訊息

On September 30, 2024, Aclarion, Inc., a Delaware-incorporated company listed on the Nasdaq Stock Market under the symbol ACON, announced the completion of a financing agreement with accredited investors. The company successfully raised $1 million through the issuance of 1,000 shares of Series C convertible preferred stock at $1,000 per share, along with warrants exercisable for 5,685,049 shares of common stock. The preferred stock comes with a 10% annual dividend, payable quarterly, and is convertible into common stock at $0.1759 per share. The warrants have a 5.5-year term and an exercise price equal to the conversion price of the preferred stock. Aclarion intends to use the proceeds for general corporate purposes. The agreement includes anti-dilution provisions and sets forth conditions under which the company can redeem the preferred shares. Additionally, Aclarion has agreed to file a registration statement with the SEC for the resale of the common stock issuable upon conversion of the preferred stock or exercise of the warrants. The securities were sold in reliance on an exemption from registration under the Securities Act.
On September 30, 2024, Aclarion, Inc., a Delaware-incorporated company listed on the Nasdaq Stock Market under the symbol ACON, announced the completion of a financing agreement with accredited investors. The company successfully raised $1 million through the issuance of 1,000 shares of Series C convertible preferred stock at $1,000 per share, along with warrants exercisable for 5,685,049 shares of common stock. The preferred stock comes with a 10% annual dividend, payable quarterly, and is convertible into common stock at $0.1759 per share. The warrants have a 5.5-year term and an exercise price equal to the conversion price of the preferred stock. Aclarion intends to use the proceeds for general corporate purposes. The agreement includes anti-dilution provisions and sets forth conditions under which the company can redeem the preferred shares. Additionally, Aclarion has agreed to file a registration statement with the SEC for the resale of the common stock issuable upon conversion of the preferred stock or exercise of the warrants. The securities were sold in reliance on an exemption from registration under the Securities Act.
2024年9月30日,總部位於特拉華州的公司 Aclarion, Inc. 在納斯達克股票交易所上市,交易代碼爲ACON,宣佈與合格投資者完成了融資協議。公司成功通過發行1,000股C輪可轉換優先股,每股發行價爲$1,000,籌集了100萬美元,同時還提供了行權價爲5,685,049股普通股的認股權證。優先股每年支付10%的年息,每季度支付,可以按照每股$0.1759的價格轉換成普通股。認股權證期限爲5.5年,行權價等於優先股的轉股價格。Aclarion打算將所得款項用於一般企業用途。協議包括防稀釋條款,並規定了公司可以贖回優先股的條件。此外,Aclarion同意向證券交易委員會提交註冊申報以便轉換優先股或行使認股權證而可轉換成的普通股重新銷售。這些證券是在《證券法》的登記豁免下出售的。
2024年9月30日,總部位於特拉華州的公司 Aclarion, Inc. 在納斯達克股票交易所上市,交易代碼爲ACON,宣佈與合格投資者完成了融資協議。公司成功通過發行1,000股C輪可轉換優先股,每股發行價爲$1,000,籌集了100萬美元,同時還提供了行權價爲5,685,049股普通股的認股權證。優先股每年支付10%的年息,每季度支付,可以按照每股$0.1759的價格轉換成普通股。認股權證期限爲5.5年,行權價等於優先股的轉股價格。Aclarion打算將所得款項用於一般企業用途。協議包括防稀釋條款,並規定了公司可以贖回優先股的條件。此外,Aclarion同意向證券交易委員會提交註冊申報以便轉換優先股或行使認股權證而可轉換成的普通股重新銷售。這些證券是在《證券法》的登記豁免下出售的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息